Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Fallopian Tube Neoplasms
×
talazoparib
×
Clear all
Filters
3
NCT03642132
2023-04-06
JAVELIN OVARIAN PARP100
Pfizer
Phase 3
Terminated
79 enrolled
18 charts